​

Funding Round

Post-IPO Debt - VBI Vaccines

Post-IPO Debt - VBI Vaccines

Investment Firm

Overview

VBI Vaccinea is a biopharmaceutical company developing novel technologies that seek to expand vaccine.

Announced Date

May 21, 2021

Funding Type

Post Ipo Debt

Highlights

Location

United States, North America

Social

Investor Lead

K2 HealthVentures

K2 HealthVentures

K2 HealthVentures is a debt and early_stage_venture and late_stage_venture and post_ipo and private_equity firm.

Participant Investors

1

Investor Name
Participant InvestorK2 HealthVentures

Round Details and Background

VBI Vaccines raised $12000000 on 2021-05-21 in Post-IPO Debt

VBI Vaccinea is a biopharmaceutical company developing novel technologies that seek to expand vaccine.

Company Funding History

25

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Aug 26, 2013
Post-IPO Debt - VBI Vaccines
-250.0K
Mar 08, 2013
Post-IPO Debt - VBI Vaccines
-751.1K
Jul 02, 2012
Post-IPO Debt - VBI Vaccines
-1.2M
Feb 13, 2012
Debt Financing - VBI Vaccines
-2.2M

Recent Activity

There is no recent news or activity for this profile.